|
IRGQ expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.206200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.477400E-01 |
| Normal-vs-Stage2 |
1.458420E-01 |
| Normal-vs-Stage3 |
8.837100E-04 |
| Normal-vs-Stage4 |
1.119970E-02 |
| Stage1-vs-Stage2 |
1.951980E-01 |
| Stage1-vs-Stage3 |
5.798300E-04 |
| Stage1-vs-Stage4 |
1.098350E-02 |
| Stage2-vs-Stage3 |
2.504400E-01 |
| Stage2-vs-Stage4 |
4.632200E-01 |
| Stage3-vs-Stage4 |
7.982400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.086380E-02 |
| Normal-vs-AfricanAmerican |
6.949400E-01 |
| Normal-vs-Asian |
8.918400E-02 |
| Caucasian-vs-AfricanAmerican |
3.120000E-02 |
| Caucasian-vs-Asian |
4.857500E-02 |
| AfricanAmerican-vs-Asian |
2.197400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.002700E-04 |
| Normal-vs-Female |
7.155800E-01 |
| Male-vs-Female |
2.3105999999995E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.666000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.956810E-01 |
| Normal-vs-Age(61-80Yrs) |
1.387870E-02 |
| Normal-vs-Age(81-100Yrs) |
5.551000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.793400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.686400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.130800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.801010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.071400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.648000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.434950E-01 |
| Normal-vs-Grade 2 |
5.437000E-01 |
| Normal-vs-Grade 3 |
2.544900E-03 |
| Normal-vs-Grade 4 |
6.658700E-03 |
| Grade 1-vs-Grade 2 |
1.722990E-01 |
| Grade 1-vs-Grade 3 |
1.317780E-02 |
| Grade 1-vs-Grade 4 |
1.668040E-02 |
| Grade 2-vs-Grade 3 |
6.217200E-03 |
| Grade 2-vs-Grade 4 |
1.453970E-02 |
| Grade 3-vs-Grade 4 |
5.648200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.038400E-01 |
| Normal-vs-ccB subtype |
7.835900E-03 |
| ccA subtype-vs-ccB subtype |
4.157800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.008400E-02 |
| Normal-vs-N1 |
1.061920E-02 |
| N0-vs-N1 |
9.702100E-02 |
|
|
